Abstract
Secondary metabolites are a reliable and very important source of medicinal compounds. While these molecules have been mined extensively, genome sequencing has suggested that there is a great deal of chemical diversity and bioactivity that remains to be discovered and characterized. A central challenge to the field is that many of the novel or poorly understood molecules are expressed at low levels in the laboratory—such molecules are often described as the ‘cryptic’ secondary metabolites. In this review, we will discuss evidence that research in this field has provided us with sufficient knowledge and tools to express and purify any secondary metabolite of interest. We will describe ‘unselective’ strategies that bring about global changes in secondary metabolite output as well as ‘selective’ strategies where a specific biosynthetic gene cluster of interest is manipulated to enhance the yield of a single product.
Similar content being viewed by others
Introduction
Secondary metabolites are biologically active small molecules that are not required for viability but which provide a competitive advantage to the producing organism. The bacterial secondary metabolites are a source of many of the antibiotics, chemotherapeutic drugs, immune suppressants and other medicines.1, 2, 3 Of bacteria, the actinomycetes and, in particular, the streptomycetes produce the greatest number of chemically diverse secondary metabolites.4, 5, 6, 7 Other major sources include soil Bacilli,8 Myxococci9, 10 and Pseudomonads.11 Two major structural classes of secondary metabolites are the polyketides3 and the nonribosomal peptides,12 both of which are produced by multienzyme biochemical pathways encoded in discrete genomic clusters.
A classical approach to the discovery of secondary metabolites having medical utility has involved screening culture supernatants for the modulation of growth of a target organism, extracting and fractionating the supernatants with organic solvents and then characterizing purified molecules using NMR, X-ray crystallography and MS. Antimicrobial activity against Staphylococcus aureus has been a commonly sought-after biological activity. Using this approach, those strains that produced antimicrobial compounds were typically found to generate, at most, one or two molecules of interest. However, the sequencing of streptomycete genomes suggests a much greater secondary metabolic potential than had been expected; it turns out that streptomycete genomes generally have the genetic capacity to produce as many as 30 distinct secondary metabolites per strain, including polyketides, nonribosomal peptides and other classes of compounds.13 It is not known how many of these pathways generate novel compounds or compounds of medicinal utility; however, these ‘cryptic’ pathways have generated considerable interest as they represent an enormous reservoir of new chemical matter and may include important drug leads.
Many secondary metabolites are expressed at low levels during laboratory growth. The factors that limit production are unknown; however, they are likely to include low expression of the biosynthetic genes or limited precursor availability during standard laboratory culture. The biological signals and regulatory networks that control the secondary metabolic genes are slowly coming into focus as a result of targeted research in this area.14, 15, 16, 17, 18, 19 So too are the metabolic networks that provide the precursors necessary for the biosynthesis of individual molecules. This knowledge has provided new strategies for tapping into this metabolite reservoir. Vital to elucidating these strategies have been the workhouse actinomycetes (Table 1). Investigations into these organisms has led to an understanding of the biochemical processes of secondary metabolite biosynthesis, as well as a growing appreciation for the extensive regulatory network that controls the expression of the metabolic genes. Information gained from studying these model systems is potentially transferable to many bacterial secondary metabolite producers.
Streptomyces coelicolor is a powerful model for secondary metabolism as it produces two pigmented secondary metabolites: actinorhodin (blue)20 and the prodiginines (red) (Figure 1).21 These compounds have facilitated genetic analysis of biosynthetic mutants, leading to the discovery of important regulators as well as many biosynthetic genes.18 The S. coelicolor genome sequence has been available for more than a decade and is well-annotated.22 There are excellent tools for chromosomal manipulation,23 reporter systems24, 25, 26, 27 as well as a growing understanding of the bacterium’s stress response mechanisms28, 29, 30 and sporulation pathway.18, 31, 32, 33, 34, 35 At present S. coelicolor has the most well-understood secondary metabolome of any streptomycete (Figure 1 and Table 2).13, 18, 22, 36 Of the 29 predicted secondary metabolites, the structures of 17 are known and there is a growing understanding of their biochemical and biological roles. We will focus on how this organism has served the field. There have been several excellent reviews of this topic generally that deal with related aspects of secondary metabolism. Given the availability of this information, we have not sought to be comprehensive in this review but have instead summarized general concepts arising from work in S. coelicolor with a particular emphasis on applying this knowledge to the discovery and characterization of cryptic secondary metabolites in other streptomycetes. We describe ‘unselective’ strategies that bring about global changes in secondary metabolite output and ‘selective’ strategies where a specific biosynthetic gene cluster of interest is manipulated to enhance the yield of a compound and illustrate how these differing approaches can be integrated into an overall strategy.
Biosynthesis of pigmented antibiotics in S. coelicolor
Actinorhodin is an aromatic polyketide synthesized by enzymes encoded in a 22-kb gene cluster (Figure 2a).37 Aromatic polyketides are an important class of medically relevant secondary metabolites: the anticancer agent daunorubicin and the tetracycline antibiotics belong to this class.38 Their production occurs using a type II, or iterative, polyketide synthase. The hallmark of iterative polyketide synthesis is the initial synthesis of the carbon backbone by the minimal polyketide synthase (actI-orf1/2/3 in the case of actinorhodin), followed by tailoring to create the final product (see Figure 2b for details). Actinorhodin production draws heavily on primary metabolism as the carbon backbone is produced entirely from fatty acid precursors, acetyl-CoA and malonyl-CoA (Figure 2b). The actinorhodin biosynthetic cluster also encodes a pathway-specific activator (actII-orf4) that activates the biosynthetic genes. This activator gene is in turn subject to the action of global regulators that can either activate or repress its expression and which presumably serve to integrate environmental and metabolic cues.
The red, cell wall-associated, pigment produced by S. coelicolor is a mixture of prodiginines—undecylprodiginine and the cyclized derivative streptorubin B being the major products.39 Prodiginines are a widespread and structurally related group of tripyrrole antibiotics currently being explored for use as chemotherapeutics. Their biosynthesis in S. coelicolor is directed by a 30-kb gene cluster (Figure 3a). Two pathway-specific transcriptional activators RedZ and RedD are required for the activation of prodiginine gene expression: RedZ is a direct activator of RedD, which then acts on the biosynthetic genes. The biosynthetic pathway itself is complicated—a bifurcated process requiring the production of two specialized precursors, 4-methoxy-2,2′-bipyrrole-5-carboxaldehyde (MBC) and 2-undecylpyrrole (see Figure 3b for details). The enzymes required for prodiginine synthesis are encoded within the biosynthetic cluster; however, proline, serine, glycine, acetyl-CoA and malonyl-CoA must be drawn from primary metabolism and the creation of the lipid moiety requires enzymes from fatty acid biosynthesis as well (Figure 3b).40
A regulatory network governing secondary metabolism
Secondary metabolism is subject to diverse regulatory inputs. Most of these pathways have been discovered through the analysis of mutations that alter yields of actinorhodin, and/or prodiginines. There does not appear to be a universal regulatory network for secondary metabolism.18, 19, 41 There are, however, many shared regulatory mechanisms, some of which are widely conserved and the general principles are similar in all streptomycetes. For example, it is very common for the expression of secondary metabolite pathway genes to be controlled by a pathway-specific regulator (Table 3), typically encoded in the cognate biosynthetic gene clusters, and these regulators are in turn under the control of the more globally acting pleiotropic regulators (Table 4).
Pathway-specific regulators
Many biosynthetic clusters encode one or more pathway-specific activators (Table 3). The Streptomyces antibiotic regulatory proteins or SARPs, characterized by a winged helix–turn–helix motif at their N terminus,42, 43 are a common type of pathway-specific regulator. For example, ActII-4, the pathway-specific activator of actinorhodin biosynthesis, binds two of the three intergenic regions (actVI-orfA/actVI-orf1 and actIII/actI-orf1) found within the biosynthetic cluster (Figure 4). These ActII-4 binding sites overlap the −35 regions of the promoters facilitating recognition by RNA polymerase.44
Some biosynthetic clusters encode pathway-specific repressors. For example, production of the S. coelicolor metabolite methylenomycin is regulated by an activator (MmyB) and two repressors (MmyR and MmfR) that repress the mmyB promoter. Repression by MmyR and MmfR is relieved by autoregulatory methylfuran signaling molecules, leading to methylenomycin production.45
Global regulators
The pleiotropic regulators influence more than one secondary metabolite. S. coelicolor’s pigments have been used as indicators for the identification and characterization of over 55 pleiotropically acting loci, most of which encode regulatory proteins (Figure 4 and Table 4). These regulators include many signal-transduction systems, suggesting that they sense and respond to the cellular environment (Table 4 and Figure 4).
One signal-transduction pathway that illustrates the complexity of sensory inputs to secondary metabolism has, at its core, the serine/threonine kinase AfsK. AfsK phosphorylates the DNA binding protein AfsR,46 an activity that is modulated by binding of the protein KbpA,47 although little is known about how this interaction is itself controlled or what purpose it serves. Phosphorylation of AfsR enhances its interaction with the promoter of the afsS gene activating its expression. AfsS, which exhibits sequence similarity to domain 3, the RNA polymerase binding moiety of the σ-factor proteins, then serves to enhance the expression of the actinorhodin and prodiginine biosynthetic genes,48, 49 although again the mechanistic details of its action are obscure.
A metabolic input that controls afsS expression is phosphate limitation,17 which is sensed by the sensor kinase PhoR leading it to phosphorylate the response regulator PhoP. PhoP∼P has a large number of targets, most of which are concerned with phosphate uptake and management; however, the afsS gene is a member of the Pho regulon, and the expression of AfsS is increased in phosphate-limiting conditions leading to increased production of actinorhodin and the prodiginines.17 The biological advantage of linking secondary metabolism to phosphate availability is unknown.
Another activating signal for the AfsK pathway is S-adenosyl-L-methionine (SAM),14, 15 an important metabolite and the methyl group donor in all organisms. Among many other roles, SAM provides a methyl group to the MBC biosynthetic pathway, a critical component in prodiginine synthesis.40 This therefore links the activation of the AfsK kinase activity to the availability of this primary metabolite.
In addition, recent work has revealed a role for AfsK in responding to cell wall stress: in response to bacitracin-induced cell wall damage, AfsK phosphorylates a cytoskeletal protein to modulate cell wall biosynthesis. A link between cell wall damage and AfsK-mediated activation of secondary metabolism has yet to be demonstrated, but may represent another avenue to improve production of secondary metabolites. It is known that yields of some metabolites, for example, jadomycin B production by S. venezulae,50 can be enhanced by heat shock—perhaps this is influenced by damage to the cell wall via this arm of the AfsK pathway?
γ-Butyrolactones: Pathway-specific and global regulators
The γ-butyrolactone (GBL) signaling molecules are produced by many streptomycetes and usually impinge directly on secondary metabolism. Their effects can be pathway specific or global. For example, in S. griseus, sporulation and secondary metabolism is controlled by the production of a single GBL, A-factor, making it a global regulator.51 In S. avermitilis, its GBL, avenolide, elicits production of the avermectins but is not believed to influence other metabolites: it therefore serves as a pathway-specific regulator.52 The GBL of S. lavendulae IM-2 is also a global regulator but has more complex effects on secondary metabolism, in that it reduces D-cycloserine production and increases nucleoside antibiotics and a blue pigment.53
In some cases, the mode of regulation by GBLs is less clear. For example, the molecule SCB1 of S. coelicolor, synthesized by ScbA, is a pathway-specific regulator of coelimycin P1, the polyketide product of the cpk gene cluster.54 However, deletion of ScbA causes a strong stimulation of both prodiginine and actinorhodin through an unknown mechanism. It is unclear whether this makes ScbA a global regulator55 or whether the loss of activation of coelimycin P1 simply favors yields from a competing pathway (ScbA is listed in both Table 3 and Table 4).
Strategies to improve secondary metabolite production and detection
Classical screening of cell culture supernatants containing many metabolites for activities of interest is appealing because it is simple and inexpensive. The problem with the established methods is that they result in the frequent rediscovery of common metabolites; such as, streptomycin, streptothricin, tetracycline and actinomycin.56 However, growing evidence suggests that we can take advantage of regulatory mechanisms to alter the spectrum of secondary metabolites produced by a strain and thereby rejuvenate this straightforward approach.
The strategies that have been taken to tap into the cryptic secondary metabolites can be described as ‘selective’, in that a single metabolite is targeted, or ‘unselective’, in that secondary metabolism is generally perturbed to enhance yields of multiple metabolites (Figure 5).
Unselective strategies
Manipulation of media and stress responses
The classical method for activating secondary metabolites involves the manipulation of culture conditions or biological stress responses. The outcomes of this approach are unpredictable in that different streptomycetes respond in different ways to each manipulation. Production of pure daptomycin, the clinically relevant form of the antimicrobial ‘calcium-dependent’ lipopeptide antibiotics produced by S. roseosporus, requires feeding with decanoic acid.57 Efficient production of jadomycin B by S. venezulae requires induction by ethanol shock or growth at high temperature (42 °C) and can be improved further by combining these two growth conditions.50, 58 This is exemplified by the OSMAC (one strain, many compounds) approach, which involves selectively changing easily accessible growth parameters to probe the secondary metabolic potential of a strain. Initial proof-of-principle work identified 20 metabolites from a single strain by changing growth conditions.59
Many secondary metabolites offer selective advantages to the producers and are only produced during these specific conditions. Siderophores are secondary metabolites that sequester iron and are expressed in low iron conditions.60, 61, 62 The carotenoids of S. coelicolor are expressed in the presence of blue light consistent with their protective role against photodamage.63 Production of ectoine and 5-hydroxyectoine protect against dehydration and thus are expressed under high salt or high temperature conditions in S. coelicolor.64 Thus, starvation for certain elements and stresses can therefore be expected to elicit some of these compounds.
Random mutagenesis using chemical mutagens or UV light has been employed to generate strains optimized for industrial production. The producer is subject to rounds of mutagenesis involving either UV or chemical mutagens, with surviving clones screened for improved activity. For example, yields of clavulanic acid from S. clavuligerus65 and rapamycin from S. hygroscopicus66 were both improved through random mutagenesis. Again, the effects of mutagenesis and multiple rounds of screening are unpredictable. Although this approach can be applied to enhancing yields of compounds produced at low levels, it is not a suitable screening platform as it cannot be easily adapted to high throughput.
Ribosomal engineering
One strikingly successful perturbation of secondary metabolite production has been developed through the observation that resistance to antibiotics enhances yields of some cryptic secondary metabolites. In particular, resistance to antibiotics that target the ribosome (for example, streptomycin, paromycin and gentamicin) frequently involving ribosomal protein S1267 or rifampicin via RNA polymerase β-subunit mutations prove effective.68 The effects of these mutations can be combined for increased effects on secondary metabolism and have been demonstrated by developing stepwise resistance for up to eight ribosomal antibiotics in S. coelicolor, with a concomitant increase in the production of actinorhodin.69
The mechanism of this fascinating effect is not entirely clear70 but involves the upregulation of pathway-specific regulators; such as, actII-orf4.71, 72 One possible explanation that has been advanced is that the alteration of ribosome function mimics the stringent response, upregulating the production of ppGpp, which is known to increase the production of some secondary metabolites.73 Regardless of how ribosome engineering actually works at the molecular level, this approach to strain improvement is advantageous in that there is no requirement for genetic engineering. Libraries of resistant mutants have been successfully screened, resulting in the discovery of novel piperidamycins.74
Small-molecule probes
The first synthetic molecule reported to influence secondary metabolism was an inhibitor of phosphopantetheinyl transferase.75 Phosphopantetheinyl transferases activate the acyl carrier protein of fatty acid biosynthesis and secondary metabolism by ‘priming’ the carrier protein. Priming occurs by the addition of a phosphopantetheinyl group and provides the reactive sulfhydryl group that tethers the new metabolites and is essential for these processes to occur. Specifically, it was found that a phosphopantetheinyl transferase inhibitor developed against Bacillus subtilis enhanced actinorhodin production when added to S. coelicolor. The mechanism for this increase is unclear as S. coelicolor encodes many phosphopantetheinyl transferases;75 however, it was proposed that the inhibition of fatty acid biosynthesis could improve precursor availability or that it could activate a stress response and that one or both of these pathways enhance actinorhodin production.75 There is at present no experimental evidence of either mechanism.
More recently, a collection of synthetic small molecules that alter secondary metabolism in S. coelicolor was identified by specifically looking for enhanced blue pigmentation.76 Of 19 compounds identified in this screen, four molecules referred to as the ARC2 series were found to be related to the antibiotic triclosan. Similarly, they appear to act by inhibiting the enoyl reductase FabI, which plays a critical role in fatty acid metabolism. It was proposed that the mechanism of action of the ARC2 series of molecules involves a buildup of fatty acid precursors that are shunted from fatty acid biosynthesis to secondary metabolism as a result of the inhibition of FabI. Consistent with the overall conservation of the fatty acid biosynthetic machinery in prokaryotes, the ARC2 series also alters the secondary metabolic profiles of many actinomycetes. Initial work demonstrated increased production of desferrioxamine B/E in S. pristinaespiralis, doxorubicin and baumycin in S. peucetius and an unknown metabolite (252.175 [M+H]+) in Kutzneria sp. 744. Other molecules from this screen had strikingly different properties. For example, one of these compounds, ARC6, elicited enhanced yields of a differing though overlapping set of secondary metabolites as ARC2. The effect of ARC6, however, appears to be restricted to S. coelicolor, indicating that it acts more as a species-specific synthetic signaling molecule.77 While this molecule is less likely to serve as a valuable screening tool, it could be used to probe the genetic and/or metabolic pathways that control and limit secondary metabolism in S. coelicolor.
Chemical manipulation of secondary metabolism is an advantageous strategy as it negates the need for genetic manipulation, which can limit the application of genetic strategies as many streptomycetes possess systems that restrict introduction of foreign DNA.78, 79, 80, 81, 82, 83, 84 It is hoped that this will serve as a valuable screening tool by activating the yields of cryptic molecules that can be purified and characterized structurally and biochemically.
Metabolic engineering
Metabolic engineering involves genetically modifying the producer organism to elevate the available levels of certain metabolic precursors. Acyl-CoA precursors are important for the production of a number of secondary metabolites; acetyl-CoA, malonyl-CoA and methylmalonyl-CoA are common building blocks of polyketide synthesis and must be available for efficient yields of the secondary metabolic products. This precursor pool can be improved by manipulating the biochemical pathways that produce or consume them; fatty acid biosynthesis, fatty acid degradation, branched chain amino-acid degradation and glucose metabolism are prevalent examples of these pathways.85 For example, overexpression of the methylmalonyl-CoA mutase pathway (mutAB) elevates the availability of methylmalonyl-CoA (by isomerization of succinyl-CoA from the tricarboxylic acid cycle) and thereby enhances the production of FK606 in S. clavuligerus.86 Disruption of zwf1 or zwf2 from the pentose phosphate pathway improves the production of acetyl-CoA and malonyl-CoA, resulting in increased production of actinorhodin in S. coelicolor87 and oxytetracycline in S. ambofaciens.88
Engineering global regulators
Strains can be genetically engineered to overexpress global regulators to elicit overall changes in secondary metabolites within the host organism or when heterologously expressed in other streptomycetes.42 For example, overexpression of various alleles of AbsA2 results in the overproduction of actinorhodin, prodiginines and CDA in S. coelicolor.89 This same allele has the capacity to enhance secondary metabolites in other streptomycetes, demonstrated by increased production of streptomycin in S. griseus and blasticidin S in S. griseochromogenes. In addition, introduction into S. flavopersicus resulted in the production of pulvomycin, previously unreported in this strain and undetectable in the absence of the AbsA2 mutant allele.89
Selective methods
The biosynthetic gene clusters can themselves be targeted to enhance yields of their products. Genes that enhance production can be overexpressed (resistance genes and pathway-specific activators) and those genes that repress production can be deleted. Secondary metabolite gene clusters of interest can be moved to alternate hosts for improved expression (heterologous expression). As the cost of high-throughput DNA sequencing drops, the strategy of simply activating novel gene clusters in newly isolated streptomycetes becomes increasingly appealing and feasible (Figure 5b).
Engineering self-resistance
A growing body of evidence suggests that self-resistance mechanisms, which are often encoded in secondary metabolic gene clusters, can influence yields of some secondary metabolites. While the mechanisms by which this occurs are not well understood, they may include limiting toxicity or preventing product inhibition of biosynthesis. It is also possible that some export proteins or other resistance determinants participate directly in biosynthesis. For example, upregulation of the resistance genes drrABC, avtAB and actAB has been applied, respectively, to improve yields of doxorubicin and daunorubicin in S. peucetius,90 avermectin production in S. avermitilis91 and actinorhodin yields in S. coelicolor.92
Regulatory engineering
As many biosynthetic clusters encode pathway-specific activators, overexpression of these activators can elevate yields of a desired metabolite and induce expression of cryptic clusters. Overexpression of the pathway-specific activators of the actinorhodin and prodiginine biosynthetic gene cluster in S. coelicolor enhances yields of the cognate metabolites.93 Similarly, overexpression of AveR and StrR enhances yields of avermectin in S. avermitilis94 and streptomycin in S. griseus,95 respectively. More importantly, overexpression of the predicted pathway-specific activator, SamR0484, was recently used to activate the previously cryptic biosynthetic gene cluster for stambomycin A–D, a family of 51-membered glycosylated macrolides, in S. ambofaciens.96
Conversely, some biosynthetic clusters encode pathway-specific repressors, which when deleted improve production. Thus, deletion of the pathway-specific repressor cmmRII in S. griseus resulted in the overproduction of chromomycin97 and similarly the deletion of AlpW in S. ambofaciens results in constitutive expression of alpomycin.98
Heterologous expression of biosynthetic gene clusters
The availability of cloning methods for managing large DNA fragments has made it possible to clone entire biosynthetic clusters, some of which are very large.99 By modifying these clones to include site-specific integration sites, it is possible to then move them into heterologous expression strains (Table 5). Streptomyces lividans and Streptomyces albus J0174 were originally used to this end because of their low secondary metabolite output and limited restriction barriers. S. venezulae has also been adapted for heterologous flavonoids biosynthesis (Table 5).
More recently, chassis strains of S. coelicolor and S. avermitilis have been developed for the expression of heterologous metabolites with very exciting results.100, 101 These chassis strains lack their own biosynthetic clusters and this reduces the metabolic competition for precursors by heterologous metabolites. These strains also greatly simplify the detection of heterologous metabolites as the LC/MS spectra of their culture supernatants are otherwise devoid of secondary metabolites. The S. avermitilis chassis, SUKA17, was created by removing ∼1.4 Mb of DNA, including biosynthetic gene clusters for the avermectins, filipin, oligomycin and terpenes. Heterologous expression of streptomycin in the resulting strain was enhanced fourfold relative to the expression in wild-type S. avermitilis (Table 5).101
The S. coelicolor chassis lacks 1.73 Mb of DNA, including the biosynthetic gene clusters for actinorhodin, the prodiginines and two other prominent metabolites. In addition, secondary metabolite-stimulating mutations in rpoB and rpsL (see ‘Ribosomal engineering’ above) were introduced to further improve yields. The resulting strain, M1154, was used for heterologous expression of the biosynthetic genes for chloramphenicol (S. venezuelae) and congocidine (S. ambofaciens), with yields enhanced by 20- to 40-fold relative to the parent S. coelicolor strain M145.100
These chassis strains may offer a general solution to the production of compounds of interest at high levels.
Genome mining
Increasingly, new secondary metabolites are being identified through mining genomes for novel biosynthetic cluster. In spite of the extraordinary structural diversity of the secondary metabolites, the enzymes that produce them are highly conserved, making it possible to identify and explore novel clusters.62, 102, 103 Non-iterative assembly as occurs in nonribosomal peptide synthesis and type I polyketide biosynthesis facilitates the prediction of pathway product structures with considerable precision.104, 105, 106 This is more difficult with the iterative processes; such as, type II and type III polyketides; however, it may still be possible to use cluster features to predict products that are likely to be distinct from known compounds.107 The genomes of many streptomycetes are now available and have been mined for their secondary metabolites; S. coelicolor is predicted to encode 29, S. avermitilis 37 and S. griseus 36 potential secondary metabolites.13
The first metabolite identified through genome mining was the nonribosomal peptide siderophore, coelichelin in S. coelicolor.62 Genome prediction aided greatly in the structural elucidation of coelichelin, as it suggested culture conditions and detection methods. While a complete structural prediction could not be made from the genomic information, accurate prediction of substrate specificity was achieved, and paved the way for genome mining for nonribosomal peptide clusters.62 The rapidly decreasing cost associated with genome sequencing suggests that this approach will gain momentum in the coming years.
Matrix-assisted laser desorption/ionization imaging
Another recent advancement involves the use of scanning MS108 to visualize directly the metabolite output of growing colonies: this approach is particularly well suited for peptides (including both nonribosomal and ribosomally produced molecules). Detection of metabolites can occur by either analysis of extracted metabolites by MS or by direct detection of the growing strain using matrix-assisted laser desorption/ionization imaging.108, 109 Metabolites of interest are fragmented and these fragments, or sequence tags, are used to deduce the identity of the amino-acid sequence, and ultimately, the identity of the peptide natural product.108 Although this technique shows considerable promise in the identification of peptide natural products, to date it has proven less effective for identifying other classes of molecules. Furthermore, metabolites produced at low levels may be less amenable to this approach. Indeed, one of the biggest successes of matrix-assisted laser desorption/ionization imaging has involved perturbation of producer organisms through, for example, co-culture with other organisms.110 Initial proof of principle demonstrated correct accurate of the previously identified ribosomal peptide AmfS from S. griseus, the nonribosomal peptide stendomycin from S. hygroscopicus and nine new ribosomal proteins including their biosynthetic clusters.108 In addition, the production of the nonribosomal peptide arylomycin was detected in the daptomycin producer S. roseosporus using imaging MS.109
Conclusion: New momentum in secondary metabolite discovery
These developments, in our view, make it possible to purify and characterize virtually any secondary metabolite encoded in any microorganism. Unselective approaches including the application of synthetic small molecules76 (SM Pimentel-Elardo and JR Nodwell, unpublished), the introduction of antibiotic-resistant mutations74 or the introduction of regulatory genes89 (Hameed, Socko and Nodwell, unpublished) can be used to enhance and alter the spectrum of secondary metabolite output in new streptomycetes: these can then be used to screen for novel activities of interest. Alternatively, selective methods including regulatory engineering or the introduction of gene clusters of interest into chassis strains can be used to investigate single molecules of interest.
Indeed, we imagine that these approaches go hand in hand. For example, if, as a result of an unselective screening procedure, a new compound is discovered, a logical next step would be the sequencing of the cognate genome and identification of the corresponding genes. Movement of these genes into a chassis strain could then be used to scale up yields of the molecule so that its mechanistic and, perhaps, clinical utility can be assessed.
We suggest that there has therefore never been a better time for a concerted effort to identify and understand the structural and functional diversity of microbial secondary metabolites, and to seek applications for these newly identified molecules.
References
Challis, G. L. & Hopwood, D. A Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc. Natl Acad. Sci. USA 100 (suppl. 2), 14555–14561 (2003).
Watve, M. G., Tickoo, R., Jog, M. M. & Bhole, B. D How many antibiotics are produced by the genus Streptomyces? Arch. Microbiol. 176, 386–390 (2001).
Weber, T., Welzel, K., Pelzer, S., Vente, A. & Wohlleben, W Exploiting the genetic potential of polyketide producing streptomycetes. J. Biotechnol. 106, 221–232 (2003).
Kinashi, H Giant linear plasmids in Streptomyces: a treasure trove of antibiotic biosynthetic clusters. J. Antibiot. (Tokyo) 64, 19–25 (2011).
Baltz, R. H Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharmacol. 8, 557–563 (2008).
Zotchev, S. B Marine actinomycetes as an emerging resource for the drug development pipelines. J. Biotechnol. 158, 168–175 (2012).
Clardy, J., Fischbach, M. A. & Walsh, C. T New antibiotics from bacterial natural products. Nat. Biotechnol. 24, 1541–1550 (2006).
Sansinenea, E. & Ortiz, A Secondary metabolites of soil Bacillus spp. Biotechnol. Lett. 33, 1523–1538 (2011).
Wenzel, S. C. & Muller, R. Myxobacteria—‘microbial factories’ for the production of bioactive secondary metabolites. Mol. Biosyst. 5, 567–574 (2009).
Gerth, K., Pradella, S., Perlova, O., Beyer, S. & Muller, R Myxobacteria: proficient producers of novel natural products with various biological activities—past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotechnol. 106, 233–253 (2003).
Gross, H. & Loper, J. E Genomics of secondary metabolite production by Pseudomonas spp. Nat. Prod. Rep. 26, 1408–1446 (2009).
Witting, K. & Sussmuth, R. D Discovery of antibacterials and other bioactive compounds from microorganisms-evaluating methodologies for discovery and generation of non-ribosomal peptide antibiotics. Curr. Drug Targets 12, 1547–1559 (2011).
Nett, M., Ikeda, H. & Moore, B. S Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat. Prod. Rep. 26, 1362–1384 (2009).
Jin, Y. Y. et al. S-adenosyl-L-methionine activates actinorhodin biosynthesis by increasing autophosphorylation of the Ser/Thr protein kinase AfsK in Streptomyces coelicolor A3(2). Biosci. Biotechnol. Biochem. 75, 910–913 (2011).
Lee, Y., Kim, K., Suh, J. W., Rhee, S. & Lim, Y Binding study of AfsK, a Ser/Thr kinase from Streptomyces coelicolor A3(2) and S-adenosyl-L-methionine. FEMS Microbiol. Lett. 266, 236–240 (2007).
Rigali, S. et al. The sugar phosphotransferase system of Streptomyces coelicolor is regulated by the GntR-family regulator DasR and links N-acetylglucosamine metabolism to the control of development. Mol. Microbiol. 61, 1237–1251 (2006).
Santos-Beneit, F., Rodriguez-Garcia, A. & Martin, J. F Complex transcriptional control of the antibiotic regulator afsS in Streptomyces: PhoP and AfsR are overlapping, competitive activators. J. Bacteriol. 193, 2242–2251 (2011).
McCormick, J. R. & Flardh, K Signals and regulators that govern Streptomyces development. FEMS Microbiol. Rev. 36, 206–231 (2012).
van Wezel, G. P. & McDowall, K. J The regulation of the secondary metabolism of Streptomyces: new links and experimental advances. Nat. Prod. Rep. 28, 1311–1333 (2011).
Wright, L. F. & Hopwood, D. A Actinorhodin is a chromosomally-determined antibiotic in Streptomyces coelicolar A3(2). J. Gen. Microbiol. 96, 289–297 (1976).
Feitelson, J. S., Malpartida, F. & Hopwood, D. A Genetic and biochemical characterization of the red gene cluster of Streptomyces coelicolor A3(2). J. Gen. Microbiol. 131, 2431–2441 (1985).
Bentley, S. D. et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417, 141–147 (2002).
Gust, B. Chapter 7. Cloning and analysis of natural product pathways. Methods Enzymol. 458, 159–180 (2009).
Craney, A. et al. A synthetic luxCDABE gene cluster optimized for expression in high-GC bacteria. Nucleic Acids Res. 35, e46 (2007).
Rodriguez-Garcia, A., Combes, P., Perez-Redondo, R., Smith, M. C. & Smith, M. C Natural and synthetic tetracycline-inducible promoters for use in the antibiotic-producing bacteria Streptomyces. Nucleic Acids Res. 33, e87 (2005).
Ingram, C., Brawner, M., Youngman, P. & Westpheling, J xylE functions as an efficient reporter gene in Streptomyces spp.: use for the study of galP1, a catabolite-controlled promoter. J. Bacteriol. 171, 6617–6624 (1989).
Sun, J., Kelemen, G. H., Fernandez-Abalos, J. M. & Bibb, M. J Green fluorescent protein as a reporter for spatial and temporal gene expression in Streptomyces coelicolor A3(2). Microbiology 145 (Part 9), 2221–2227 (1999).
Kormanec, J., Sevcikova, B., Halgasova, N., Knirschova, R. & Rezuchova, B Identification and transcriptional characterization of the gene encoding the stress-response sigma factor sigma(H) in Streptomyces coelicolor A3(2). FEMS Microbiol. Lett. 189, 31–38 (2000).
Kelemen, G. H. et al. A connection between stress and development in the multicellular prokaryote Streptomyces coelicolor A3(2). Mol. Microbiol. 40, 804–814 (2001).
Lee, E. J. et al. A master regulator sigmaB governs osmotic and oxidative response as well as differentiation via a network of sigma factors in Streptomyces coelicolor. Mol. Microbiol. 57, 1252–1264 (2005).
Chater, K. F Regulation of sporulation in Streptomyces coelicolor A3(2): a checkpoint multiplex? Curr. Opin. Microbiol. 4, 667–673 (2001).
Claessen, D., de Jong, W., Dijkhuizen, L. & Wosten, H. A Regulation of Streptomyces development: reach for the sky!. Trends Microbiol. 14, 313–319 (2006).
Willey, J. M., Willems, A., Kodani, S. & Nodwell, J. R Morphogenetic surfactants and their role in the formation of aerial hyphae in Streptomyces coelicolor. Mol. Microbiol. 59, 731–742 (2006).
Flardh, K., Findlay, K. C. & Chater, K. F Association of early sporulation genes with suggested developmental decision points in Streptomyces coelicolor A3(2). Microbiology 145 (Part 9), 2229–2243 (1999).
Kelemen, G. H. et al. The positions of the sigma-factor genes, whiG and sigF, in the hierarchy controlling the development of spore chains in the aerial hyphae of Streptomyces coelicolor A3(2). Mol. Microbiol. 21, 593–603 (1996).
Gomes-Escribano, J. P et al. Structure and biosynthesis of the unusual polyketide alkaloid coelimycin P1, a metabolic product of the cpk gene cluster of Streptomyces coelicolor M145. Chem. Sci. 3, 2716 (2012).
Okamoto, S., Taguchi, T., Ochi, K. & Ichinose, K Biosynthesis of actinorhodin and related antibiotics: discovery of alternative routes for quinone formation encoded in the act gene cluster. Chem. Biol. 16, 226–236 (2009).
Zhan, J Biosynthesis of bacterial aromatic polyketides. Curr. Top. Med. Chem. 9, 1958–1610 (2009).
Mo, S. et al. Elucidation of the Streptomyces coelicolor pathway to 2-undecylpyrrole, a key intermediate in undecylprodiginine and streptorubin B biosynthesis. Chem. Biol. 15, 137–148 (2008).
Williamson, N. R., Fineran, P. C., Leeper, F. J. & Salmond, G. P The biosynthesis and regulation of bacterial prodiginines. Nat. Rev. Microbiol. 4, 887–899 (2006).
Chater, K. F. & Horinouchi, S Signalling early developmental events in two highly diverged Streptomyces species. Mol. Microbiol. 48, 9–15 (2003).
Martin, J. F. & Liras, P Engineering of regulatory cascades and networks controlling antibiotic biosynthesis in Streptomyces. Curr. Opin. Microbiol. 13, 263–273 (2010).
Wietzorrek, A. & Bibb, M A novel family of proteins that regulates antibiotic production in streptomycetes appears to contain an OmpR-like DNA-binding fold. Mol. Microbiol. 25, 1181–1184 (1997).
Arias, P., Fernandez-Moreno, M. A. & Malpartida, F Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3(2) as a DNA-binding protein. J. Bacteriol. 181, 6958–6968 (1999).
O'Rourke, S. et al. Extracellular signalling, translational control, two repressors and an activator all contribute to the regulation of methylenomycin production in Streptomyces coelicolor. Mol. Microbiol. 71, 763–778 (2009).
Matsumoto, A., Hong, S. K., Ishizuka, H., Horinouchi, S. & Beppu, T Phosphorylation of the AfsR protein involved in secondary metabolism in Streptomyces species by a eukaryotic-type protein kinase. Gene 146, 47–56 (1994).
Umeyama, T. & Horinouchi, S Autophosphorylation of a bacterial serine/threonine kinase, AfsK, is inhibited by KbpA, an AfsK-binding protein. J. Bacteriol. 183, 5506–5512 (2001).
Lee, P. C., Umeyama, T. & Horinouchi, S afsS is a target of AfsR, a transcriptional factor with ATPase activity that globally controls secondary metabolism in Streptomyces coelicolor A3(2). Mol. Microbiol. 43, 1413–1430 (2002).
Tanaka, A., Takano, Y., Ohnishi, Y. & Horinouchi, S AfsR recruits RNA polymerase to the afsS promoter: a model for transcriptional activation by SARPs. J. Mol. Biol. 369, 322–333 (2007).
Doull, J. L., Ayer, S. W., Singh, A. K. & Thibault, P Production of a novel polyketide antibiotic, jadomycin B, by Streptomyces venezuelae following heat shock. J. Antibiot. (Tokyo) 46, 869–871 (1993).
Horinouchi, S A microbial hormone, A-factor, as a master switch for morphological differentiation and secondary metabolism in Streptomyces griseus. Front. Biosci. 7, d2045–d2057 (2002).
Kitani, S. et al. Avenolide, a Streptomyces hormone controlling antibiotic production in Streptomyces avermitilis. Proc. Natl Acad. Sci. USA 108, 16410–16415 (2011).
Kitani, S., Doi, M., Shimizu, T., Maeda, A. & Nihira, T Control of secondary metabolism by farX, which is involved in the gamma-butyrolactone biosynthesis of Streptomyces lavendulae FRI-5. Arch. Microbiol 192, 211–220 (2010).
Takano, E. et al. A bacterial hormone (the SCB1) directly controls the expression of a pathway-specific regulatory gene in the cryptic type I polyketide biosynthetic gene cluster of Streptomyces coelicolor. Mol. Microbiol. 56, 465–479 (2005).
Butler, M. J. et al. Deletion of scbA enhances antibiotic production in Streptomyces lividans. Appl. Microbiol. Biotechnol. 61, 512–516 (2003).
Baltz, R. H. Marcel Faber Roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? J. Ind. Microbiol. Biotechnol. 33, 507–513 (2006).
Yu, G. et al. Strain improvement of Streptomyces roseosporus for daptomycin production by rational screening of He-Ne laser and NTG induced mutants and kinetic modeling. Appl. Biochem. Biotechnol. 163, 729–743 (2011).
Jakeman, D. L., Graham, C. L., Young, W. & Vining, L. C Culture conditions improving the production of jadomycin B. J. Ind. Microbiol. Biotechnol. 33, 767–772 (2006).
Bode, H. B., Bethe, B., Hofs, R. & Zeeck, A Big effects from small changes: possible ways to explore nature’s chemical diversity. Chembiochem 3, 619–627 (2002).
Barona-Gomez, F. et al. Multiple biosynthetic and uptake systems mediate siderophore-dependent iron acquisition in Streptomyces coelicolor A3(2) and Streptomyces ambofaciens ATCC 23877. Microbiology 152, 3355–3366 (2006).
Barona-Gomez, F., Wong, U., Giannakopulos, A. E., Derrick, P. J. & Challis, G. L Identification of a cluster of genes that directs desferrioxamine biosynthesis in Streptomyces coelicolor M145. J. Am. Chem. Soc. 126, 16282–16283 (2004).
Lautru, S., Deeth, R. J., Bailey, L. M. & Challis, G. L Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat. Chem. Biol. 1, 265–269 (2005).
Takano, H., Obitsu, S., Beppu, T. & Ueda, K Light-induced carotenogenesis in Streptomyces coelicolor A3(2): identification of an extracytoplasmic function sigma factor that directs photodependent transcription of the carotenoid biosynthesis gene cluster. J. Bacteriol. 187, 1825–1832 (2005).
Bursy, J. et al. Synthesis and uptake of the compatible solutes ectoine and 5-hydroxyectoine by Streptomyces coelicolor A3(2) in response to salt and heat stresses. Appl. Environ. Microbiol. 74, 7286–7296 (2008).
Medema, M. H., Alam, M. T., Breitling, R. & Takano, E The future of industrial antibiotic production: from random mutagenesis to synthetic biology. Bioeng. Bugs 2, 230–233 (2011).
Cheng, Y. R., Huang, J., Qiang, H., Lin, W. L. & Demain, A. L Mutagenesis of the rapamycin producer Streptomyces hygroscopicus FC904. J. Antibiot. (Tokyo) 54, 967–972 (2001).
Shima, J., Hesketh, A., Okamoto, S., Kawamoto, S. & Ochi, K Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2). J. Bacteriol. 178, 7276–7284 (1996).
Xu, J., Tozawa, Y., Lai, C., Hayashi, H. & Ochi, K A rifampicin resistance mutation in the rpoB gene confers ppGpp-independent antibiotic production in Streptomyces coelicolor A3(2). Mol. Genet. Genom. 268, 179–189 (2002).
Wang, G., Hosaka, T. & Ochi, K Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl. Environ. Microbiol. 74, 2834–2840 (2008).
Nodwell, J. R Novel links between antibiotic resistance and antibiotic production. J. Bacteriol. 189, 3683–3685 (2007).
Nishimura, K., Hosaka, T., Tokuyama, S., Okamoto, S. & Ochi, K Mutations in rsmG, encoding a 16S rRNA methyltransferase, result in low-level streptomycin resistance and antibiotic overproduction in Streptomyces coelicolor A3(2). J. Bacteriol. 189, 3876–3883 (2007).
Okamoto, S. et al. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol. Microbiol 63, 1096–1106 (2007).
Chakraburtty, R. & Bibb, M The ppGpp synthetase gene (relA) of Streptomyces coelicolor A3(2) plays a conditional role in antibiotic production and morphological differentiation. J. Bacteriol. 179, 5854–5861 (1997).
Hosaka, T. et al. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 27, 462–464 (2009).
Foley, T. L., Young, B. S. & Burkart, M. D Phosphopantetheinyl transferase inhibition and secondary metabolism. FEBS J. 276, 7134–7145 (2009).
Craney, A., Ozimok, C., Pimentel-Elardo, S. M., Capretta, A. & Nodwell, J. R Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 19, 1020–1027 (2012).
Ahmed, S., Craney, A., Pimentel-Elardo, S. M. & Nodwell, J. R A synthetic, species-specific activator of secondary metabolism and sporulation in Streptomyces coelicolor. Chembiochem 14, 83–91 (2013).
Suzuki, H., Takahashi, S., Osada, H. & Yoshida, K Improvement of transformation efficiency by strategic circumvention of restriction barriers in Streptomyces griseus. J. Microbiol. Biotechnol. 21, 675–678 (2011).
Godany, A., Farkasovska, J., Bukovska, G. & Timko, J Connection between foreign DNA replication and induced expression of the restriction–modification system in Streptomyces aureofaciens. Folia Microbiol. (Praha) 46, 193–196 (2001).
Lyutzkanova, D., Stoilova-Disheva, M. & Peltekova, V The restriction–modification system in Streptomyces flavopersicus. Folia Microbiol. (Praha) 46, 119–122 (2001).
Matseliukh, A. B Genetic transformation of Streptomyces globisporus strain 1912: restriction barrier and plasmid compatibility. Mikrobiol. Z. 63, 15–22 (2001).
Alvarez, M. A., Gomez, A., Gomez, P., Brooks, J. E. & Rodicio, M. R Comparative analysis of expression of the SalI restriction–modification system in Escherichia coli and Streptomyces. Mol. Gen. Genet. 253, 74–80 (1996).
Alvarez, M. A., Gomez, A., Gomez, P. & Rodicio, M. R Expression of the SalI restriction–modification system of Streptomyces albus G in Escherichia coli. Gene 157, 231–232 (1995).
Zotchev, S. B., Schrempf, H. & Hutchinson, C. R Identification of a methyl-specific restriction system mediated by a conjugative element from Streptomyces bambergiensis. J. Bacteriol. 177, 4809–4812 (1995).
Olano, C., Lombo, F., Mendez, C. & Salas, J. A Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab. Eng. 10, 281–292 (2008).
Mo, S., Ban, Y. H., Park, J. W., Yoo, Y. J. & Yoon, Y. J Enhanced FK506 production in Streptomyces clavuligerus CKD1119 by engineering the supply of methylmalonyl-CoA precursor. J. Ind. Microbiol. Biotechnol. 36, 1473–1482 (2009).
Ryu, Y. G., Butler, M. J., Chater, K. F. & Lee, K. J Engineering of primary carbohydrate metabolism for increased production of actinorhodin in Streptomyces coelicolor. Appl. Environ. Microbiol. 72, 7132–7139 (2006).
Liu, Z., Guo, M., Qian, J., Zhuang, Y. & Zhang, S Disruption of zwf2 gene to improve oxytetracyline biosynthesis in Streptomyces rimosus M4018. Wei Sheng Wu Xue Bao 48, 21–25 (2008).
McKenzie, N. L. et al. Induction of antimicrobial activities in heterologous streptomycetes using alleles of the Streptomyces coelicolor gene absA1. J. Antibiot. (Tokyo) 63, 177–182 (2010).
Malla, S., Niraula, N. P., Liou, K. & Sohng, J. K Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. Microbiol. Res. 165, 259–267 (2010).
Qiu, J. et al. Overexpression of the ABC transporter AvtAB increases avermectin production in Streptomyces avermitilis. Appl. Microbiol. Biotechnol. 92, 337–345 (2011).
Xu, Y., Willems, A., Au-Yeung, C., Tahlan, K. & Nodwell, J. R A two-step mechanism for the activation of actinorhodin export and resistance in Streptomyces coelicolor. MBio 3, e00191–12 (2012).
McKenzie, N. L. & Nodwell, J. R Phosphorylated AbsA2 negatively regulates antibiotic production in Streptomyces coelicolor through interactions with pathway-specific regulatory gene promoters. J. Bacteriol. 189, 5284–5292 (2007).
Guo, J. et al. The pathway-specific regulator AveR from Streptomyces avermitilis positively regulates avermectin production while it negatively affects oligomycin biosynthesis. Mol. Genet. Genom. 283, 123–133 (2010).
Retzlaff, L. & Distler, J The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites. Mol. Microbiol. 18, 151–162 (1995).
Laureti, L. et al. Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens. Proc. Natl Acad. Sci. USA 108, 6258–6263 (2011).
Menendez, N., Brana, A. F., Salas, J. A. & Mendez, C Involvement of a chromomycin ABC transporter system in secretion of a deacetylated precursor during chromomycin biosynthesis. Microbiology 153, 3061–3070 (2007).
Bunet, R. et al. Characterization and manipulation of the pathway-specific late regulator AlpW reveals Streptomyces ambofaciens as a new producer of kinamycins. J. Bacteriol. 193, 1142–1153 (2011).
Huang, S., Li, N., Zhou, J. & He, J Construction of a new bacterial artificial chromosome (BAC) vector for cloning of large DNA fragments and heterologous expression in Streptomyces. Wei Sheng Wu Xue Bao 52, 30–37 (2012).
Gomez-Escribano, J. P. & Bibb, M. J Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol. 4, 207–215 (2011).
Komatsu, M., Uchiyama, T., Omura, S., Cane, D. E. & Ikeda, H Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc. Natl Acad. Sci. USA 107, 2646–2651 (2010).
Cane, D. E. & Ikeda, H Exploration and mining of the bacterial terpenome. Acc. Chem. Res. 45, 463–472 (2012).
Challis, G. L Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology 154, 1555–1569 (2008).
Koglin, A. & Walsh, C. T Structural insights into nonribosomal peptide enzymatic assembly lines. Nat. Prod. Rep. 26, 987–1000 (2009).
Rottig, M. et al. NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity. Nucleic Acids Res 39, W362–W367 (2011).
Chen, A. Y., Cane, D. E. & Khosla, C Structure-based dissociation of a type I polyketide synthase module. Chem. Biol. 14, 784–792 (2007).
Yadav, G., Gokhale, R. S. & Mohanty, D Towards prediction of metabolic products of polyketide synthases: an in silico analysis. PLoS Comput. Biol. 5, e1000351 (2009).
Kersten, R. D. et al. A mass spectrometry-guided genome mining approach for natural product peptidogenomics. Nat. Chem. Biol. 7, 794–802 (2011).
Liu, W. T., Kersten, R. D., Yang, Y. L., Moore, B. S. & Dorrestein, P. C Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporus. J. Am. Chem. Soc. 133, 18010–18013 (2011).
Yang, Y. L., Xu, Y., Straight, P. & Dorrestein, P. C Translating metabolic exchange with imaging mass spectrometry. Nat. Chem. Biol. 5, 885–887 (2009).
McCormick, M. H., McGuire, J. M., Pittenger, G. E., Pittenger, R. C. & Stark, W. M Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiot. Annu. 3, 606–611 (1955).
Burg, R. W. et al. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents Chemother. 15, 361–367 (1979).
Reading, C. & Cole, M Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11, 852–857 (1977).
Rudd, B. A. & Hopwood, D. A Genetics of actinorhodin biosynthesis by Streptomyces coelicolor A3(2). J. Gen. Microbiol. 114, 35–43 (1979).
Waksman, S. A., Reilly, H. C. & Johnstone, D. B Isolation of Streptomycin-producing Strains of Streptomyces griseus. J. Bacteriol. 52, 393–397 (1946).
He, J., Magarvey, N., Piraee, M. & Vining, L. C The gene cluster for chloramphenicol biosynthesis in Streptomyces venezuelae ISP5230 includes novel shikimate pathway homologues and a monomodular non-ribosomal peptide synthetase gene. Microbiology 147, 2817–2829 (2001).
Tuan, J. S. et al. Cloning of genes involved in erythromycin biosynthesis from Saccharopolyspora erythraea using a novel actinomycete–Escherichia coli cosmid. Gene 90, 21–29 (1990).
Beer, L. L. & Moore, B. S Biosynthetic convergence of salinosporamides A and B in the marine actinomycete Salinispora tropica. Org. Lett. 9, 845–848 (2007).
Austin, M. B. et al. Crystal structure of a bacterial type III polyketide synthase and enzymatic control of reactive polyketide intermediates. J. Biol. Chem. 279, 45162–45174 (2004).
Hojati, Z. et al. Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor. Chem. Biol. 9, 1175–1187 (2002).
Zhao, B. et al. Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2). J. Biol. Chem 283, 8183–8189 (2008).
Cane, D. E. & Watt, R. M Expression and mechanistic analysis of a germacradienol synthase from Streptomyces coelicolor implicated in geosmin biosynthesis. Proc. Natl Acad. Sci. USA 100, 1547–1551 (2003).
Takano, E. et al. Purification and structural determination of SCB1, a gamma-butyrolactone that elicits antibiotic production in Streptomyces coelicolor A3(2). J. Biol. Chem. 275, 11010–11016 (2000).
Pawlik, K., Kotowska, M., Chater, K. F., Kuczek, K. & Takano, E A cryptic type I polyketide synthase (cpk) gene cluster in Streptomyces coelicolor A3(2). Arch. Microbiol. 187, 87–99 (2007).
Pawlik, K., Kotowska, M. & Kolesinski, P Streptomyces coelicolor A3(2) produces a new yellow pigment associated with the polyketide synthase Cpk. J. Mol. Microbiol. Biotechnol. 19, 147–151 (2010).
Poralla, K., Muth, G. & Hartner, T Hopanoids are formed during transition from substrate to aerial hyphae in Streptomyces coelicolor A3(2). FEMS Microbiol. Lett. 189, 93–95 (2000).
Song, L. et al. Type III polyketide synthase beta-ketoacyl-ACP starter unit and ethylmalonyl-CoA extender unit selectivity discovered by Streptomyces coelicolor genome mining. J. Am. Chem. Soc. 128, 14754–14755 (2006).
Komatsu, M., Tsuda, M., Omura, S., Oikawa, H. & Ikeda, H Identification and functional analysis of genes controlling biosynthesis of 2-methylisoborneol. Proc. Natl Acad. Sci. USA 105, 7422–7427 (2008).
Wright, L. F. & Hopwood, D. A Identification of the antibiotic determined by the SCP1 plasmid of Streptomyces coelicolor A3(2). J. Gen. Microbiol. 95, 96–106 (1976).
Corre, C., Song, L., O'Rourke, S., Chater, K. F. & Challis, G. L 2-Alkyl-4-hydroxymethylfuran-3-carboxylic acids, antibiotic production inducers discovered by Streptomyces coelicolor genome mining. Proc. Natl Acad. Sci. USA 105, 17510–17515 (2008).
Kodani, S. et al. The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor. Proc. Natl Acad. Sci. USA 101, 11448–11453 (2004).
Davis, N. K. & Chater, K. F Spore colour in Streptomyces coelicolor A3(2) involves the developmentally regulated synthesis of a compound biosynthetically related to polyketide antibiotics. Mol. Microbiol. 4, 1679–1691 (1990).
Fernandez-Moreno, M. A., Caballero, J. L., Hopwood, D. A. & Malpartida, F The act cluster contains regulatory and antibiotic export genes, direct targets for translational control by the bldA tRNA gene of Streptomyces. Cell 66, 769–780 (1991).
Ryding, N. J., Anderson, T. B. & Champness, W. C Regulation of the Streptomyces coelicolor calcium-dependent antibiotic by absA, encoding a cluster-linked two-component system. J. Bacteriol. 184, 794–805 (2002).
Li, Y. Q., Chen, P. L., Chen, S. F., Wu, D. & Zheng, J A pair of two-component regulatory genes ecrA1/A2 in S. coelicolor. J. Zhejiang Univ. Sci. 5, 173–179 (2004).
Narva, K. E. & Feitelson, J. S Nucleotide sequence and transcriptional analysis of the redD locus of Streptomyces coelicolor A3(2). J. Bacteriol. 172, 326–333 (1990).
White, J. & Bibb, M bldA dependence of undecylprodigiosin production in Streptomyces coelicolor A3(2) involves a pathway-specific regulatory cascade. J. Bacteriol. 179, 627–633 (1997).
Hindra, P. & Elliot, M. A Regulation of a novel gene cluster involved in secondary metabolite production in Streptomyces coelicolor. J. Bacteriol. 192, 4973–4982 (2010).
Sheeler, N. L., MacMillan, S. V. & Nodwell, J. R Biochemical activities of the absA two-component system of Streptomyces coelicolor. J. Bacteriol. 187, 687–696 (2005).
Brian, P., Riggle, P. J., Santos, R. A. & Champness, W. C Global negative regulation of Streptomyces coelicolor antibiotic synthesis mediated by an absA-encoded putative signal transduction system. J. Bacteriol. 178, 3221–3231 (1996).
Anderson, T. B., Brian, P. & Champness, W. C Genetic and transcriptional analysis of absA, an antibiotic gene cluster-linked two-component system that regulates multiple antibiotics in Streptomyces coelicolor. Mol. Microbiol. 39, 553–566 (2001).
Horinouchi, S AfsR as an integrator of signals that are sensed by multiple serine/threonine kinases in Streptomyces coelicolor A3(2). J. Ind. Microbiol. Biotechnol. 30, 462–467 (2003).
Floriano, B. & Bibb, M afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2). Mol. Microbiol. 21, 385–396 (1996).
Shu, D. et al. afsQ1-Q2-sigQ is a pleiotropic but conditionally required signal transduction system for both secondary metabolism and morphological development in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 81, 1149–1160 (2009).
Yepes, A., Rico, S., Rodriguez-Garcia, A., Santamaria, R. I. & Diaz, M Novel two-component systems implied in antibiotic production in Streptomyces coelicolor. PLoS One 6, e19980 (2011).
Tunca, S., Barreiro, C., Coque, J. J. & Martin, J. F Two overlapping antiparallel genes encoding the iron regulator DmdR1 and the Adm proteins control siderophore [correction of sedephore] and antibiotic biosynthesis in Streptomyces coelicolor A3(2). FEBS J. 276, 4814–4827 (2009).
Yu, Z. et al. Differential regulation of antibiotic biosynthesis by DraR-K, a novel two-component system in Streptomyces coelicolor. Mol. Microbiol. 85, 535–556 (2012).
Lu, Y. et al. Characterization of a novel two-component regulatory system involved in the regulation of both actinorhodin and a type I polyketide in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 77, 625–635 (2007).
Uguru, G. C. et al. Transcriptional activation of the pathway-specific regulator of the actinorhodin biosynthetic genes in Streptomyces coelicolor. Mol. Microbiol. 58, 131–150 (2005).
Hesketh, A., Kock, H., Mootien, S. & Bibb, M The role of absC, a novel regulatory gene for secondary metabolism, in zinc-dependent antibiotic production in Streptomyces coelicolor A3(2). Mol. Microbiol. 74, 1427–1444 (2009).
Onaka, H., Nakagawa, T. & Horinouchi, S Involvement of two A-factor receptor homologues in Streptomyces coelicolor A3(2) in the regulation of secondary metabolism and morphogenesis. Mol. Microbiol. 28, 743–753 (1998).
Rigali, S. et al. Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep. 9, 670–675 (2008).
Yang, Y. H. et al. NdgR, an IclR-like regulator involved in amino-acid-dependent growth, quorum sensing, and antibiotic production in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 82, 501–511 (2009).
Ou, X., Zhang, B., Zhang, L., Zhao, G. & Ding, X Characterization of rrdA, a TetR family protein gene involved in the regulation of secondary metabolism in Streptomyces coelicolor. Appl. Environ. Microbiol. 75, 2158–2165 (2009).
Feng, W. H., Mao, X. M., Liu, Z. H. & Li, Y. Q The ECF sigma factor SigT regulates actinorhodin production in response to nitrogen stress in Streptomyces coelicolor. Appl. Microbiol. Biotechnol. 92, 1009–1021 (2011).
den Hengst, C. D. et al. Genes essential for morphological development and antibiotic production in Streptomyces coelicolor are targets of BldD during vegetative growth. Mol. Microbiol. 78, 361–379 (2010).
Elliot, M. A., Locke, T. R., Galibois, C. M. & Leskiw, B. K BldD from Streptomyces coelicolor is a non-essential global regulator that binds its own promoter as a dimer. FEMS Microbiol. Lett. 225, 35–40 (2003).
Tran, N. T., Den Hengst, C. D., Gomez-Escribano, J. P. & Buttner, M. J Identification and characterization of CdgB, a diguanylate cyclase involved in developmental processes in Streptomyces coelicolor. J. Bacteriol. 193, 3100–3108 (2011).
Li, W. et al. Identification of a gene negatively affecting antibiotic production and morphological differentiation in Streptomyces coelicolor A3(2). J. Bacteriol. 188, 8368–8375 (2006).
Zhang, L., Li, W. C., Zhao, C. H., Chater, K. F. & Tao, M. F NsdB, a TPR-like-domain-containing protein negatively affecting production of antibiotics in Streptomyces coelicolor A3 (2). Wei Sheng Wu Xue Bao 47, 849–854 (2007).
van Wezel, G. P. et al. ssgA is essential for sporulation of Streptomyces coelicolor A3(2) and affects hyphal development by stimulating septum formation. J. Bacteriol. 182, 5653–5662 (2000).
Traag, B. A., Kelemen, G. H. & Van Wezel, G. P Transcription of the sporulation gene ssgA is activated by the IclR-type regulator SsgR in a whi-independent manner in Streptomyces coelicolor A3(2). Mol. Microbiol. 53, 985–1000 (2004).
Chater, K. F. & Chandra, G The use of the rare UUA codon to define ‘expression space’ for genes involved in secondary metabolism, development and environmental adaptation in Streptomyces. J. Microbiol. 46, 1–11 (2008).
Price, B., Adamidis, T., Kong, R. & Champness, W A Streptomyces coelicolor antibiotic regulatory gene, absB, encodes an RNase III homolog. J. Bacteriol. 181, 6142–6151 (1999).
Adamidis, T. & Champness, W Genetic analysis of absB, a Streptomyces coelicolor locus involved in global antibiotic regulation. J. Bacteriol. 174, 4622–4628 (1992).
Xu, W., Huang, J., Lin, R., Shi, J. & Cohen, S. N Regulation of morphological differentiation in S. coelicolor by RNase III (AbsB) cleavage of mRNA encoding the AdpA transcription factor. Mol. Microbiol. 75, 781–791 (2010).
Wang, G., Tanaka, Y. & Ochi, K. The G243D mutation (afsB mutation) in the principal sigma factor sigmaHrdB alters intracellular ppGpp level and antibiotic production in Streptomyces coelicolor A3(2). Microbiology 156, 2384–2392 (2010).
Saito, N. et al. EshA accentuates ppGpp accumulation and is conditionally required for antibiotic production in Streptomyces coelicolor A3(2). J. Bacteriol. 188, 4952–4961 (2006).
Ochi, K. & Hosoya, Y Genetic mapping and characterization of novel mutations which suppress the effect of a relC mutation on antibiotic production in Streptomyces coelicolor A3(2). J. Antibiot. (Tokyo) 51, 592–595 (1998).
Sun, J., Hesketh, A. & Bibb, M Functional analysis of relA and rshA, two relA/spoT homologues of Streptomyces coelicolor A3(2). J. Bacteriol. 183, 3488–3498 (2001).
Xie, P., Zeng, A. & Qin, Z cmdABCDEF, a cluster of genes encoding membrane proteins for differentiation and antibiotic production in Streptomyces coelicolor A3(2). BMC Microbiol. 9, 157 (2009).
Zhang, Y., Wang, L., Zhang, S., Yang, H. & Tan, H hmgA, transcriptionally activated by HpdA, influences the biosynthesis of actinorhodin in Streptomyces coelicolor. FEMS Microbiol. Lett. 280, 219–225 (2008).
Ou, X. et al. SarA influences the sporulation and secondary metabolism in Streptomyces coelicolor M145. Acta Biochim. Biophys. Sin. (Shanghai) 40, 877–882 (2008).
D’Alia, D. et al. Deletion of the signalling molecule synthase ScbA has pleiotropic effects on secondary metabolite biosynthesis, morphological differentiation and primary metabolism in Streptomyces coelicolor A3(2). Microb. Biotechnol. 4, 239–251 (2011).
Eustaquio, A. S. et al. Heterologous expression of novobiocin and clorobiocin biosynthetic gene clusters. Appl. Environ. Microbiol. 71, 2452–2459 (2005).
Cane, D. E., Luo, G., Khosla, C., Kao, C. M. & Katz, L Erythromycin biosynthesis. Highly efficient incorporation of polyketide chain elongation intermediates into 6-deoxyerythronolide B in an engineered Streptomyces host. J. Antibiot. (Tokyo) 48, 647–651 (1995).
Jung, W. S. et al. Heterologous expression of tylosin polyketide synthase and production of a hybrid bioactive macrolide in Streptomyces venezuelae. Appl. Microbiol. Biotechnol. 72, 763–769 (2006).
Park, S. R., Ahn, M. S., Han, A. R., Park, J. W. & Yoon, Y. J Enhanced flavonoid production in Streptomyces venezuelae via metabolic engineering. J. Microbiol. Biotechnol. 21, 1143–1146 (2011).
Chater, K. F. & Wilde, L. C Streptomyces albus G mutants defective in the SalGI restriction–modification system. J. Gen. Microbiol. 116, 323–334 (1980).
Hopwood, D. A., Kieser, T., Wright, H. M. & Bibb, M. J Plasmids, recombination and chromosome mapping in Streptomyces lividans 66. J. Gen. Microbiol. 129, 2257–2269 (1983).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Craney, A., Ahmed, S. & Nodwell, J. Towards a new science of secondary metabolism. J Antibiot 66, 387–400 (2013). https://doi.org/10.1038/ja.2013.25
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ja.2013.25
Keywords
This article is cited by
-
Potential therapeutic targets for combating Mycoplasma genitalium
3 Biotech (2023)
-
Biosynthetic pathway of peucemycin and identification of its derivative from Streptomyces peucetius
Applied Microbiology and Biotechnology (2023)
-
Whole-genome sequencing and analysis of Streptomyces strains producing multiple antinematode drugs
BMC Genomics (2022)
-
Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria
Scientific Reports (2021)
-
Chemical entrapment and killing of insects by bacteria
Nature Communications (2020)